Your Search Results

How to deal with secondary mitral regurgitation in 2025?

20 May 2025 – From EuroPCR 2025

Delve into the evolving management of secondary mitral regurgitation, and the critical role of the Heart Team. This session replay presents the latest clinical trials, treatment guidelines, and a case-based discussion covering medical and interventional strategies, heart failure optimization, frailty assessment, and advanced imaging techniques.

How to deal with secondary mitral regurgitation in 2025?

How a new generation of coronary sinus reducer can significantly expand treatment options for patients with coronary microvascular dysfunction

21 May 2025 – From EuroPCR 2025

Discover the latest on managing coronary microvascular dysfunction (CMD) with insights from EuroPCR 2025. This session explores how physiology testing helps identify CMD endotypes in the cathlab and highlights the limitations of ETT for patients experiencing angina or dyspnea at rest. Learn about the A-FLUX coronary...

How a new generation of coronary sinus reducer can significantly expand treatment options for patients with coronary microvascular dysfunction

Intracoronary value for PCI optimisation

20 May 2025 – From EuroPCR 2025

Optimize your PCI strategies with intracoronary insights in this session highlighting plaque stabilization, coronary stent optimization under pressure, and the critical role of intravascular imaging beyond angiography. Learn management approaches for traumatic coronary artery dissection and explore diagnosis of delayed stent fracture using enhanced stent visualization...

Intracoronary value for PCI optimisation

Simultaneous publications EuroPCR 2026

View the list of EuroPCR 2026 simultaneous publications in different cardiology and interventional cardiology journals

Academic Research Consortium on LAA closure

21 May 2025 – From EuroPCR 2025

Gain comprehensive understanding of the Academic Research Consortium's achievements in left atrial appendage (LAA) closure. Learn how standardized endpoints are streamlined for randomized controlled trials and how collaborative efforts homogenize definitions to advance clinical research.

Academic Research Consortium on LAA closure

Yu-Wei Chen

Taichung

Nicola Corcione

Castel Volturno, Italy

Hyunsu Ha

Samera Shakir

Berne, Switzerland

Zhifeng Yao

Shanghai, China

Jining He

Beijing, China

Sergio Caravita

Dalmine (Bg), Italy

Martin Bennett

Cambridge, United Kingdom

Annemieke Van der Heijden

Semih Oktay

Md, United States of America

Angela Torres

Transcatheter tricuspid valve replacement in carcinoid heart disease: A multimodality‑guided, patient-centered approach

17 Apr 2026

A 74-year-old woman with carcinoid syndrome develops progressive NYHA III dyspnoea and marked fatigue, despite well-controlled systemic symptoms. Echocardiography reveals torrential tricuspid regurgitation with carcinoid valve involvement, while surgical risk is deemed high due to age, frailty, and systemic disease. How would your Heart Team approach this...